Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $182,818 | 108 | 81.4% |
| Travel and Lodging | $18,499 | 83 | 8.2% |
| Food and Beverage | $13,268 | 720 | 5.9% |
| Consulting Fee | $9,945 | 2 | 4.4% |
| Education | $36.06 | 6 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $92,005 | 172 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $57,160 | 97 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $34,881 | 94 | $0 (2024) |
| AbbVie Inc. | $22,166 | 83 | $0 (2023) |
| Novo Nordisk Inc | $9,921 | 184 | $0 (2022) |
| Corcept Therapeutics | $4,263 | 55 | $0 (2024) |
| Abbott Laboratories | $673.10 | 22 | $0 (2024) |
| Lilly USA, LLC | $572.30 | 44 | $0 (2024) |
| Amgen Inc. | $413.97 | 17 | $0 (2024) |
| Antares Pharma, Inc. | $354.83 | 26 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,138 | 57 | Corcept Therapeutics ($357.26) |
| 2023 | $857.41 | 37 | Abbott Laboratories ($218.99) |
| 2022 | $1,737 | 98 | AstraZeneca Pharmaceuticals LP ($275.82) |
| 2021 | $8,017 | 104 | AstraZeneca Pharmaceuticals LP ($5,158) |
| 2020 | $9,333 | 86 | AstraZeneca Pharmaceuticals LP ($7,191) |
| 2019 | $42,756 | 155 | AstraZeneca Pharmaceuticals LP ($13,852) |
| 2018 | $57,341 | 152 | Janssen Pharmaceuticals, Inc ($19,367) |
| 2017 | $103,388 | 230 | AstraZeneca Pharmaceuticals LP ($47,795) |
All Payment Transactions
919 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $15.21 | General |
| Category: Insulin Pump | ||||||
| 12/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $7.74 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/13/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $59.35 | General |
| Category: Endocrinology | ||||||
| 12/09/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $89.73 | General |
| Category: Endocrinology | ||||||
| 12/05/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $10.53 | General |
| Category: DIABETES | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $33.17 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/20/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $28.86 | General |
| Category: Cardio-renal | ||||||
| 11/14/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: Endocrinology | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $10.27 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/17/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $6.79 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/17/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $2.91 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/10/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $8.50 | General |
| Category: Endocrinology | ||||||
| 10/09/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: Diabetes | ||||||
| 10/07/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Neuromodulation | ||||||
| 09/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $11.03 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/18/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 09/18/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $11.36 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 09/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $110.80 | General |
| Category: DIABETES | ||||||
| 09/12/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 09/05/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Endocrinology | ||||||
| 09/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $9.88 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/04/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: Diabetes | ||||||
| 08/28/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 228 | 454 | $98,695 | $32,073 |
| 2022 | 4 | 172 | 328 | $63,539 | $24,527 |
| 2021 | 4 | 127 | 248 | $45,034 | $18,392 |
| 2020 | 5 | 151 | 321 | $43,442 | $21,772 |
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 116 | 289 | $72,250 | $23,125 | 32.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 39 | 45 | $7,875 | $2,623 | 33.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $5,985 | $2,295 | 38.3% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 40 | 84 | $6,720 | $2,057 | 30.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 17 | $5,865 | $1,973 | 33.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 93 | 212 | $46,799 | $18,489 | 39.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 33 | 40 | $5,985 | $2,491 | 41.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 21 | 21 | $6,355 | $2,127 | 33.5% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 25 | 55 | $4,400 | $1,419 | 32.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 70 | 166 | $32,702 | $13,511 | 41.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 21 | 24 | $6,072 | $2,646 | 43.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 20 | 27 | $3,780 | $1,429 | 37.8% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 16 | 31 | $2,480 | $805.80 | 32.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 84 | 223 | $30,374 | $15,500 | 51.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 19 | 19 | $4,413 | $2,167 | 49.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 15 | 16 | $3,234 | $1,657 | 51.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 20 | 32 | $2,940 | $1,646 | 56.0% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2020 | 13 | 31 | $2,480 | $802.30 | 32.4% |
About Dr. Theodore Roosevelt, M.D
Dr. Theodore Roosevelt, M.D is a Internal Medicine healthcare provider based in Boise, Idaho. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1699754697.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Theodore Roosevelt, M.D has received a total of $224,566 in payments from pharmaceutical and medical device companies, with $1,138 received in 2024. These payments were reported across 919 transactions from 38 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($182,818).
As a Medicare-enrolled provider, Roosevelt has provided services to 678 Medicare beneficiaries, totaling 1,351 services with total Medicare billing of $96,763. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Diabetes & Metabolism
- Location Boise, ID
- Active Since 01/10/2006
- Last Updated 05/17/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1699754697
Products in Payments
- FARXIGA (Drug) $84,060
- INVOKANA (Drug) $57,134
- SOLIQUA (Drug) $21,086
- Synthroid (Drug) $16,099
- TOUJEO (Drug) $13,486
- Victoza (Drug) $8,617
- BYDUREON (Drug) $7,592
- Korlym (Drug) $4,263
- SYNTHROID (Drug) $3,146
- Androgel (Drug) $2,863
- Ozempic (Drug) $587.85
- Repatha (Biological) $324.44
- JARDIANCE (Drug) $309.19
- Tresiba (Drug) $294.95
- TRULICITY (Drug) $288.90
- XYOSTED (Drug) $225.57
- FREESTYLE LIBRE 3 (Device) $204.52
- LEQVIO (Drug) $199.74
- JANUVIA (Drug) $194.91
- NOCDURNA (Drug) $158.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Boise
Shaalan Beg, Md, MD
Internal Medicine — Payments: $185,291
Ashley Evans, Md, MD
Internal Medicine — Payments: $95,647
Huiling Qi, M.d, M.D
Internal Medicine — Payments: $38,813
Dr. Adam Grimaldi, M.d, M.D
Internal Medicine — Payments: $23,011
Dr. Carolyn Bridges, M.d, M.D
Internal Medicine — Payments: $19,716
Kendra Coonse, M.d, M.D
Internal Medicine — Payments: $16,388